服薬アドヒアランスデバイス市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、薬剤別、地域別、競合別、2020年～2030年

服薬アドヒアランスデバイスの世界市場規模は2024年に33億8,000万米ドルで、予測期間中のCAGRは5.17%で2030年には45億4,000万米ドルに達すると予測されています。

世界の服薬アドヒアランスデバイス市場は、技術の進歩や慢性疾患の有病率の増加に牽引され、大きな成長を遂げています。スマートピルディスペンサー、ウェアラブルトラッカー、アドヒアランスソフトウェアを含むこれらのデバイスは、処方された投薬レジメンに対する患者のコンプライアンスを高めることを目的としています。人口の高齢化、ヘルスケアコストの上昇、効率的な慢性疾患管理の必要性などの要因が、これらのソリューションの需要に寄与しています。

市場促進要因

心血管疾患の有病率の増加

主な市場課題

デバイスの高コスト

主要市場動向

デジタルヘルス技術の統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の服薬アドヒアランスデバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（ハードウェア中心vs/sソフトウェア中心）
  • 薬剤別（心臓血管、中枢神経系、糖尿病、腫瘍学、消化器、筋骨格系、その他）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024年）
• 市場マップ

第6章 北米の服薬アドヒアランスデバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の服薬アドヒアランスデバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の服薬アドヒアランスデバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の服薬アドヒアランスデバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの服薬アドヒアランスデバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界の服薬アドヒアランスデバイス市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Becton, Dickinson, and Company（CareFusion）
• DrFirst.com,Inc.
• AdhereTech Inc.
• MedMinder.
• Caredose.
• Fruitech Ltd.
• PHC Holdings Corporation.
• MedAdvisor International Pty Ltd.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Medication Adherence Devices Market was valued at USD 3.38 billion in 2024 and is expected to reach USD 4.54 billion by 2030 with a CAGR of 5.17% during the forecast period. The global medication adherence devices market is experiencing significant growth, driven by technological advancements and the increasing prevalence of chronic diseases. These devices, which include smart pill dispensers, wearable trackers, and adherence software, aim to enhance patient compliance with prescribed medication regimens. Factors such as the aging population, rising healthcare costs, and the need for efficient chronic disease management are contributing to the demand for these solutions.

Key Market Drivers

Growing Prevalence of Cardiovascular Diseases

Most often, chronic diseases require a long therapeutic intervention by using high-dose drugs and any interruption in the medication intake can create fatal consequences which need strict medication adherence and will further boost the growth of the market during the forecast period. Cardiovascular diseases are one of the major chronic diseases across the world. Coronary heart syndrome, cerebrovascular diseases, rheumatic heart diseases, and other illnesses are among the most commonly observed cardiovascular diseases. According to the World Health Organization (WHO), 32% of all deaths across the globe i.e., 17.9 million people die due to CVD every year. The increasing geriatric population is susceptible to heart defects due to progressive deterioration in the structure and function of the heart, which largely contributes to the high burden of CVDs; thereby triggering the increased adoption of advanced medication adherence during the forecast period. Due to genetic factors, environmental factors, the oxidative stress heart diseases are increasing rapidly. The improvement of chronic diseases necessitates clinical intervention, which is accomplished by increasing the participation of patient-centric medication adherence programs, fueling the expansion of the global medication adherence devices market.

Key Market Challenges

High Cost of Devices

The high cost of medication adherence devices is one of the major challenges hindering the growth of the global market. While the market for these devices is expanding, the price of advanced adherence solutions remains a significant barrier, particularly in lower-income regions or for patients without comprehensive insurance coverage. These devices often incorporate sophisticated technologies such as real-time monitoring, artificial intelligence (AI), connectivity with mobile apps, and integration with healthcare systems. While these features enhance patient care and improve medication adherence, they also drive up the production and retail costs of the devices. For patients, especially those in underserved communities or with limited financial resources, the high cost of adherence devices can be prohibitive. As a result, many individuals may forgo purchasing these devices, opting instead for traditional, less effective methods of medication management, or they may not adhere to their prescribed medication regimen at all. This non-adherence can lead to deteriorating health, more frequent hospitalizations, and increased healthcare costs, further exacerbating the issue.

For healthcare providers and insurers, the cost of medication adherence devices can also be a challenge. Despite the potential for long-term cost savings by improving medication adherence and reducing hospital readmissions, the upfront costs of these devices can deter healthcare systems from adopting them on a widespread scale. This reluctance to invest in adherence technology can slow down the overall market growth and adoption.

However, as demand for these devices increases, there may be opportunities for manufacturers to reduce costs through economies of scale, advancements in technology, and greater competition in the market. The initiatives to offer subsidized devices through insurance coverage or government programs could help alleviate the financial burden on both patients and healthcare providers. Until then, the high cost of devices remains a significant challenge that the market must address for continued growth.

Key Market Trends

Integration of Digital Health Technologies

The integration of digital health technologies is one of the most significant trends driving the growth of the global medication adherence devices market. As healthcare increasingly shifts toward more connected, data-driven approaches, digital health technologies are transforming how medication adherence is monitored and managed. Devices that incorporate mobile apps, cloud-based platforms, artificial intelligence (AI), and the Internet of Things (IoT) are becoming essential tools for improving patient adherence to prescribed medication regimens. This integration enables real-time tracking and monitoring of patients, allowing for immediate intervention if necessary, which ultimately enhances patient outcomes. One of the most notable benefits of integrating digital health technologies into medication adherence devices is the ability to provide personalized care. Mobile apps that sync with adherence devices can send reminders and notifications based on a patient's unique medication schedule and dosage requirements. These apps also allow patients to track their progress, monitor side effects, and manage multiple medications simultaneously. The convenience and tailored approach help improve adherence rates, particularly for patients managing chronic conditions that require long-term medication.

Key Market Players

• Becton, Dickinson, and Company (CareFusion)
• DrFirst.com,Inc.
• AdhereTech Inc.
• MedMinder.
• Caredose.
• Fruitech Ltd.
• PHC Holdings Corporation.
• MedAdvisor International Pty Ltd.

Report Scope:

In this report, the Global Medication Adherence Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medication Adherence Devices Market, By Type:

• Hardware Centric
• Software Centric

Medication Adherence Devices Market, By Medication:

• Cardiovascular
• Central Nervous System
• Diabetes
• Oncology
• Gastrointestinal
• Musculoskeletal
• Others

Medication Adherence Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medication Adherence Devices Market.

Available Customizations:

Global Medication Adherence Devices Market report with the given market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medication Adherence Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Hardware Centric v/s Software Centric)
  • 5.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Medication Adherence Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Hardware Centric v/s Software Centric)
  • 6.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Medication Adherence Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Medication
  • 6.3.2. Canada Medication Adherence Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Medication
  • 6.3.3. Mexico Medication Adherence Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Medication

7. Europe Medication Adherence Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Hardware Centric v/s Software Centric)
  • 7.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Medication Adherence Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Medication
  • 7.3.2. Germany Medication Adherence Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Medication
  • 7.3.3. United Kingdom Medication Adherence Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Medication
  • 7.3.4. Italy Medication Adherence Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Medication
  • 7.3.5. Spain Medication Adherence Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Medication

8. Asia-Pacific Medication Adherence Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Hardware Centric v/s Software Centric)
  • 8.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Medication Adherence Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Medication
  • 8.3.2. India Medication Adherence Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Medication
  • 8.3.3. Japan Medication Adherence Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Medication
  • 8.3.4. South Korea Medication Adherence Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Medication
  • 8.3.5. Australia Medication Adherence Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Medication

9. South America Medication Adherence Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Hardware Centric v/s Software Centric)
  • 9.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Medication Adherence Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Medication
  • 9.3.2. Argentina Medication Adherence Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Medication
  • 9.3.3. Colombia Medication Adherence Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Medication

10. Middle East and Africa Medication Adherence Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Hardware Centric v/s Software Centric)
  • 10.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Medication Adherence Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Medication
  • 10.3.2. Saudi Arabia Medication Adherence Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Medication
  • 10.3.3. UAE Medication Adherence Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Medication

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Medication Adherence Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Becton, Dickinson, and Company (CareFusion)
• 15.2. DrFirst.com,Inc.
• 15.3. AdhereTech Inc.
• 15.4. MedMinder.
• 15.5. Caredose.
• 15.6. Fruitech Ltd.
• 15.7. PHC Holdings Corporation.
• 15.8. MedAdvisor International Pty Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer